Opthea (ASX:OPT) said that there remained material uncertainty as to its ability to continue as a "going concern," according to a Wednesday Australian bourse filing.
The company noted it continues an active discussion with investors as required by a development funding agreement to explore possible options to deliver the best outcome for the firm and its shareholders.
The firm said it plans to use the net proceeds from any current or future offering or capital raise to advance clinical development, chemistry, manufacturing and controls, regulatory activities of any new asset, and for general corporate purposes.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。